| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. | SVP AND CFO | Common Stock | 28.1K | $996K | $35.42 | Jun 14, 2024 | Direct |
| Celldex Therapeutics, Inc. | SVP AND CFO | Incentive Stock Option (Right to Buy) | 63.6K | Jun 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | Jun 14, 2024 | 5 | -$403K | 4 | Jun 18, 2024 | SVP AND CFO |
| CLDX | Celldex Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | SVP AND CFO |
| CLDX | Celldex Therapeutics, Inc. | May 30, 2024 | 3 | -$932K | 4 | Jun 3, 2024 | SVP AND CFO |
| CLDX | Celldex Therapeutics, Inc. | Jan 2, 2024 | 2 | $29.9K | 4 | Jan 4, 2024 | SVP AND CFO |
| CLDX | Celldex Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | SVP AND CFO |
| CLDX | Celldex Therapeutics, Inc. | Aug 11, 2022 | 10 | -$635K | 4 | Aug 15, 2022 | SVP AND CFO |
| CLDX | Celldex Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | SVP AND CFO |
| CLDX | Celldex Therapeutics, Inc. | Dec 23, 2021 | 5 | -$359K | 4 | Dec 28, 2021 | SVP and CFO |
| CLDX | Celldex Therapeutics, Inc. | Nov 15, 2021 | 6 | -$374K | 4 | Nov 17, 2021 | SVP and CFO |
| CLDX | Celldex Therapeutics, Inc. | Aug 10, 2021 | 6 | -$207 | 4 | Aug 12, 2021 | SVP and CFO |
| CLDX | Celldex Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | SVP and CFO |